Gevo Inc. (NASDAQ:GEVO) has been given an average broker rating score of 2.00 (Buy) from the two brokers that provide coverage for the stock, Zacks Investment Research reports. One research analyst has rated the stock with a hold recommendation and one has assigned a strong buy recommendation to the company.
Analysts have set a 1-year consensus target price of $2.30 for the company and are anticipating that the company will post ($0.09) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Gevo an industry rank of 69 out of 265 based on the ratings given to its competitors.
Separately, Zacks Investment Research upgraded shares of Gevo from a “hold” rating to a “buy” rating and set a $0.50 price objective on the stock in a report on Monday, September 26th.
Gevo (NASDAQ:GEVO) traded down 2.3048% during trading on Tuesday, reaching $0.4705. 2,964,499 shares of the company’s stock traded hands. The firm’s 50 day moving average is $0.52 and its 200 day moving average is $0.46. The company’s market cap is $23.09 million. Gevo has a 12 month low of $0.22 and a 12 month high of $2.24.
Gevo (NASDAQ:GEVO) last announced its quarterly earnings data on Tuesday, August 9th. The company reported ($0.15) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.27) by $0.12. Gevo had a negative net margin of 133.03% and a negative return on equity of 67.50%. The business had revenue of $8.11 million for the quarter, compared to analyst estimates of $8.90 million. Analysts anticipate that Gevo will post ($0.72) EPS for the current year.
A hedge fund recently raised its stake in Gevo stock. Vanguard Group Inc. boosted its stake in Gevo Inc. (NASDAQ:GEVO) by 357.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 815,973 shares of the company’s stock after buying an additional 637,440 shares during the period. Vanguard Group Inc. owned 3.55% of Gevo worth $481,000 as of its most recent SEC filing. 3.50% of the stock is owned by institutional investors.
Gevo, Inc (Gevo) is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Gevo Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo Inc. and related companies with MarketBeat.com's FREE daily email newsletter.